BACKGROUND: Although cardiac allograft vasculopathy (CAV) is typically characterized by diffuse coronary intimal thickening with pathological vessel remodeling, plaque instability may also play an important role in CAV. Previous studies of native coronary atherosclerosis have demonstrated associations between attenuated-signal plaque (ASP), plaque instability, and adverse clinical events. OBJECTIVES: This study's aim was to characterize the association between ASP and long-term mortality post-heart transplantation. METHODS: In 105 heart transplant recipients, serial (baseline and 1-year post-transplant) intravascular ultrasound was performed in the first 50 mm of the left anterior descending artery. The ASP score was calculated by grading the measured angle of attenuation from grades 0 to 4 (specifically, 0°, 1° to 90°, 91° to 180°, 181° to 270°, and >270°) at 1-mm intervals. The primary endpoint was all-cause death or retransplantation. RESULTS: At 1-year post-transplant, 10.5% of patients demonstrated ASP progression (newly developed or increased ASP). Patients with ASP progression had a higher incidence of acute cellular rejection during the first year (63.6% vs. 22.3%; p = 0.006) and tendency for greater intimal growth (percent intimal volume: 9.2 ± 9.3% vs. 4.4 ± 5.3%; p = 0.07) than those without. Over a median follow-up of 4.6 years, there was a significantly lower event-free survival rate in patients with ASP progression at 1-year post-transplant compared with those without. In contrast, maximum intimal thickness did not predict long-term mortality. CONCLUSIONS: ASP progression appears to reflect chronic inflammation related to acute cellular rejection and is an independent predictor of long-term mortality after heart transplantation. Serial assessments of plaque instability may enhance identification of high-risk patients who may benefit from closer follow-up and targeted medical therapies.
RCT Entities:
BACKGROUND: Although cardiac allograft vasculopathy (CAV) is typically characterized by diffuse coronary intimal thickening with pathological vessel remodeling, plaque instability may also play an important role in CAV. Previous studies of native coronary atherosclerosis have demonstrated associations between attenuated-signal plaque (ASP), plaque instability, and adverse clinical events. OBJECTIVES: This study's aim was to characterize the association between ASP and long-term mortality post-heart transplantation. METHODS: In 105 heart transplant recipients, serial (baseline and 1-year post-transplant) intravascular ultrasound was performed in the first 50 mm of the left anterior descending artery. The ASP score was calculated by grading the measured angle of attenuation from grades 0 to 4 (specifically, 0°, 1° to 90°, 91° to 180°, 181° to 270°, and >270°) at 1-mm intervals. The primary endpoint was all-cause death or retransplantation. RESULTS: At 1-year post-transplant, 10.5% of patients demonstrated ASP progression (newly developed or increased ASP). Patients with ASP progression had a higher incidence of acute cellular rejection during the first year (63.6% vs. 22.3%; p = 0.006) and tendency for greater intimal growth (percent intimal volume: 9.2 ± 9.3% vs. 4.4 ± 5.3%; p = 0.07) than those without. Over a median follow-up of 4.6 years, there was a significantly lower event-free survival rate in patients with ASP progression at 1-year post-transplant compared with those without. In contrast, maximum intimal thickness did not predict long-term mortality. CONCLUSIONS:ASP progression appears to reflect chronic inflammation related to acute cellular rejection and is an independent predictor of long-term mortality after heart transplantation. Serial assessments of plaque instability may enhance identification of high-risk patients who may benefit from closer follow-up and targeted medical therapies.
Authors: Jun Pu; Gary S Mintz; Sinan Biro; Jin-Bae Lee; Stephen T Sum; Sean P Madden; Allen P Burke; Pei Zhang; Ben He; James A Goldstein; Gregg W Stone; James E Muller; Renu Virmani; Akiko Maehara Journal: J Am Coll Cardiol Date: 2014-03-26 Impact factor: 24.094
Authors: Josef Stehlik; Leah B Edwards; Anna Y Kucheryavaya; Christian Benden; Jason D Christie; Anne I Dipchand; Fabienne Dobbels; Richard Kirk; Axel O Rahmel; Marshall I Hertz Journal: J Heart Lung Transplant Date: 2012-10 Impact factor: 10.247
Authors: Jorg van Loosdregt; Matthijs F M van Oosterhout; Annette H Bruggink; Dick F van Wichen; Joyce van Kuik; Erica de Koning; Carla C Baan; Nicolaas de Jonge; Frits H J Gmelig-Meyling; Roel A de Weger Journal: Circulation Date: 2006-10-02 Impact factor: 29.690
Authors: Haiyan Li; Koji Tanaka; Hitoshi Anzai; Brandy Oeser; Dominic Lai; Jon A Kobashigawa; Jonathan M Tobis Journal: J Am Coll Cardiol Date: 2006-05-26 Impact factor: 24.094
Authors: Bo Zheng; Akiko Maehara; Gary S Mintz; Tamim M Nazif; Yarden Waksman; Fuyu Qiu; Luz Jaquez; LeRoy E Rabbani; Mark A Apfelbaum; Ziad A Ali; Kate Dalton; Lei Song; Ke Xu; Charles C Marboe; Donna M Mancini; Giora Weisz Journal: Int J Cardiovasc Imaging Date: 2015-09-25 Impact factor: 2.357
Authors: Xiaofan Wu; Gary S Mintz; Kai Xu; Alexandra J Lansky; Bernhard Witzenbichler; Giulio Guagliumi; Bruce Brodie; Mirle A Kellett; Ovidiu Dressler; Helen Parise; Roxana Mehran; Gregg W Stone; Akiko Maehara Journal: JACC Cardiovasc Interv Date: 2011-05 Impact factor: 11.195
Authors: G Vassalli; A Gallino; M Weis; W von Scheidt; L Kappenberger; L K von Segesser; J-J Goy Journal: Eur Heart J Date: 2003-07 Impact factor: 29.983
Authors: W C Little; M Constantinescu; R J Applegate; M A Kutcher; M T Burrows; F R Kahl; W P Santamore Journal: Circulation Date: 1988-11 Impact factor: 29.690
Authors: K Fischer; S Ohori; F C Meral; M Uehara; S Giannini; T Ichimura; R N Smith; F A Jolesz; I Guleria; Y Zhang; P J White; N J McDannold; K Hoffmeister; M M Givertz; R Abdi Journal: Am J Transplant Date: 2017-02-01 Impact factor: 8.086
Authors: Ward A Heggermont; Leen Delrue; Karen Dierickx; Riet Dierckx; Sofie Verstreken; Marc Goethals; Jozef Bartunek; Marc Vanderheyden Journal: Transplant Direct Date: 2020-04-15